For those taking certain cholesterol-lowering drugs, this will not come as good news. A new study suggests that certain statins, the widely-used cholesterol lowering drugs, may increase your chances of developing type-two diabetes. The risk was greatest for those taking Lipitor, Crestor and Zocor.
Researchers focused on a half million Ontario residents and found the overall odds of developing diabetes were low in patients with prescribed statins. Still, people taking Lipitor had a 22% higher risk of early-onset diabetes, Crestor users had an 18% higher risk and those on Zocor had a 10% increased risk. All of this was relative to those taking yet another statin, Pravachol. Pravachol appears to have a favorable effect on diabetes.
Researchers say this doesn't mean people should stop taking their statins. The study only showed an association between statin use and a higher risk of diabetes. It did not prove a cause and effect relationship.
One doctor says while this is an important study evaluating the relationship between statins and the risk of diabetes, the study has several flaws that make it difficult to generalize the results. There was no data regarding weight, ethnicity and family history. All of those are important risk factors for development of diabetes.
Another researcher wrote, "The overall benefit of statins still clearly outweighs the potential risk of incident diabetes."
People with type-two diabetes have higher than normal blood-sugar levels because their bodies don't make or properly use insulin. Researchers said it's possible that certain statins impair insulin secretion and inhibit insulin release, which could help explain the findings.







